Prokidney (PROK) Cash from Investing Activities (2021 - 2026)

Prokidney's (PROK) quarterly Cash from Investing Activities came in at $34.8 million in Q1 2026, up 23.11% year-on-year from $28.3 million in Q1 2025, and up 23.97% on a QoQ basis from $28.1 million in Q4 2025.

Prokidney (PROK) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 6 years of Cash from Investing Activities data on file, last reported at $34.8 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 23.11% year-over-year to $34.8 million in Q1 2026; TTM through Mar 2026 was $110.5 million, a 1239.68% increase from a year earlier, with the FY2025 full-year figure at $104.0 million, up 409.28% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $34.8 million, up from $28.1 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for PROK reached as high as $58.4 million in Q1 2024 and fell as low as -$192.6 million in Q1 2023.
  • Historically, Cash from Investing Activities has averaged -$10.1 million across 5 years, with a median of -$207000.0 in 2022.
  • Across the five-year window, Cash from Investing Activities plunged 31221.57% in 2023 and surged 317.21% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$306000.0 in 2022, then plunged by 31221.57% to -$95.8 million in 2023, then surged by 115.73% to $15.1 million in 2024, then soared by 86.29% to $28.1 million in 2025, then gained by 23.97% to $34.8 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $34.8 million in Q1 2026, $28.1 million in Q4 2025, and $29.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 Prokidney 96.00 Mn 96.00 Mn - 34.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 34.83 Mn
Mar 31, 2026 34.83 Mn
Dec 31, 2025 28.09 Mn
Dec 31, 2025 28.09 Mn
Sep 30, 2025 29.02 Mn
Sep 30, 2025 29.02 Mn
Jun 30, 2025 18.57 Mn
Jun 30, 2025 18.57 Mn
Mar 31, 2025 28.29 Mn
Mar 31, 2025 28.29 Mn
Dec 31, 2024 15.08 Mn
Dec 31, 2024 15.08 Mn
Sep 30, 2024 -81.64 Mn
Sep 30, 2024 -81.64 Mn
Jun 30, 2024 28.57 Mn
Jun 30, 2024 28.57 Mn
Mar 31, 2024 58.40 Mn
Mar 31, 2024 58.40 Mn
Dec 31, 2023 -95.84 Mn
Dec 31, 2023 -95.84 Mn